Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled trial of BYS30 granules in knee osteoarthritis
CTR20252639Phase 2Active
- Sponsor
- Baiyunshan Pharmaceutical General Factory
- Start
- Jul 2025
- Countries
- 1
01
Overview
A Phase 2 trial of BYS30 in knee osteoarthritis (OA), sponsored by Baiyunshan Pharmaceutical General Factory. Started Jul 2025; status: active.
02
Drugs
BYS30
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on CTR20252639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252639.